Bikaji Foods International Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 16, 2025, 8:01 pm

Competitors of Bikaji Foods International Ltd

All Competitor Stocks of Bikaji Foods International Ltd

Quarterly Result

Last Updated: August 2, 2025, 1:05 am

Below is a detailed analysis of the quarterly data for Bikaji Foods International Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 624.00 Cr.. The value appears strong and on an upward trend. It has increased from 585.00 Cr. (Mar 2025) to 624.00 Cr., marking an increase of 39.00 Cr..
• For Expenses, as of Jun 2025, the value is 525.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 506.00 Cr. (Mar 2025) to 525.00 Cr., marking an increase of 19.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 99.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Mar 2025) to 99.00 Cr., marking an increase of 20.00 Cr..
• For OPM %, as of Jun 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 13.00% (Mar 2025) to 16.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 8.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 85.00 Cr.. The value appears strong and on an upward trend. It has increased from 65.00 Cr. (Mar 2025) to 85.00 Cr., marking an increase of 20.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 63.00 Cr.. The value appears strong and on an upward trend. It has increased from 48.00 Cr. (Mar 2025) to 63.00 Cr., marking an increase of 15.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.52. The value appears strong and on an upward trend. It has increased from 1.93 (Mar 2025) to 2.52, marking an increase of 0.59.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:49 am

Growth

Last Updated: September 4, 2025, 9:45 pm

Balance Sheet

Last Updated: October 10, 2025, 1:31 pm

Below is a detailed analysis of the balance sheet data for Bikaji Foods International Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 25.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,405.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,200.00 Cr. (Mar 2024) to 1,405.00 Cr., marking an increase of 205.00 Cr..
• For Borrowings, as of Mar 2025, the value is 171.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 139.00 Cr. (Mar 2024) to 171.00 Cr., marking an increase of 32.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 155.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 138.00 Cr. (Mar 2024) to 155.00 Cr., marking an increase of 17.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,756.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,503.00 Cr. (Mar 2024) to 1,756.00 Cr., marking an increase of 253.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 736.00 Cr.. The value appears to be declining and may need further review. It has decreased from 753.00 Cr. (Mar 2024) to 736.00 Cr., marking a decrease of 17.00 Cr..
• For CWIP, as of Mar 2025, the value is 94.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2024) to 94.00 Cr., marking an increase of 82.00 Cr..
• For Investments, as of Mar 2025, the value is 185.00 Cr.. The value appears strong and on an upward trend. It has increased from 60.00 Cr. (Mar 2024) to 185.00 Cr., marking an increase of 125.00 Cr..
• For Other Assets, as of Mar 2025, the value is 741.00 Cr.. The value appears strong and on an upward trend. It has increased from 677.00 Cr. (Mar 2024) to 741.00 Cr., marking an increase of 64.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,756.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,503.00 Cr. (Mar 2024) to 1,756.00 Cr., marking an increase of 253.00 Cr..

Notably, the Reserves (1,405.00 Cr.) exceed the Borrowings (171.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Bikaji Foods International Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.02. This value is within the healthy range. It has decreased from 10.63 (Mar 24) to 8.02, marking a decrease of 2.61.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.02. This value is within the healthy range. It has decreased from 10.63 (Mar 24) to 8.02, marking a decrease of 2.61.
• For Cash EPS (Rs.), as of Mar 25, the value is 11.01. This value is within the healthy range. It has decreased from 12.92 (Mar 24) to 11.01, marking a decrease of 1.91.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.20. It has increased from 48.57 (Mar 24) to 55.20, marking an increase of 6.63.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.20. It has increased from 48.57 (Mar 24) to 55.20, marking an increase of 6.63.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 104.63. It has increased from 93.03 (Mar 24) to 104.63, marking an increase of 11.60.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 14.41. This value is within the healthy range. It has decreased from 16.72 (Mar 24) to 14.41, marking a decrease of 2.31.
• For PBIT / Share (Rs.), as of Mar 25, the value is 11.16. This value is within the healthy range. It has decreased from 14.32 (Mar 24) to 11.16, marking a decrease of 3.16.
• For PBT / Share (Rs.), as of Mar 25, the value is 10.55. This value is within the healthy range. It has decreased from 13.90 (Mar 24) to 10.55, marking a decrease of 3.35.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.76. This value is within the healthy range. It has decreased from 10.52 (Mar 24) to 7.76, marking a decrease of 2.76.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.01. This value is within the healthy range. It has decreased from 10.61 (Mar 24) to 8.01, marking a decrease of 2.60.
• For PBDIT Margin (%), as of Mar 25, the value is 13.77. This value is within the healthy range. It has decreased from 17.97 (Mar 24) to 13.77, marking a decrease of 4.20.
• For PBIT Margin (%), as of Mar 25, the value is 10.66. This value is within the healthy range. It has decreased from 15.39 (Mar 24) to 10.66, marking a decrease of 4.73.
• For PBT Margin (%), as of Mar 25, the value is 10.08. This value is within the healthy range. It has decreased from 14.93 (Mar 24) to 10.08, marking a decrease of 4.85.
• For Net Profit Margin (%), as of Mar 25, the value is 7.41. This value is within the healthy range. It has decreased from 11.31 (Mar 24) to 7.41, marking a decrease of 3.90.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.66. This value is below the healthy minimum of 8. It has decreased from 11.40 (Mar 24) to 7.66, marking a decrease of 3.74.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.52. This value is below the healthy minimum of 15. It has decreased from 21.80 (Mar 24) to 14.52, marking a decrease of 7.28.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.94. This value is within the healthy range. It has decreased from 27.24 (Mar 24) to 16.94, marking a decrease of 10.30.
• For Return On Assets (%), as of Mar 25, the value is 10.37. This value is within the healthy range. It has decreased from 17.32 (Mar 24) to 10.37, marking a decrease of 6.95.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has increased from 0.09 (Mar 24) to 0.11, marking an increase of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.51. It has decreased from 1.66 (Mar 24) to 1.51, marking a decrease of 0.15.
• For Current Ratio (X), as of Mar 25, the value is 2.60. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 2.60, marking an increase of 0.32.
• For Quick Ratio (X), as of Mar 25, the value is 2.22. This value exceeds the healthy maximum of 2. It has increased from 1.90 (Mar 24) to 2.22, marking an increase of 0.32.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 27.59. This value exceeds the healthy maximum of 8. It has increased from 17.99 (Mar 24) to 27.59, marking an increase of 9.60.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 12.46. This value is below the healthy minimum of 20. It has increased from 7.04 (Mar 24) to 12.46, marking an increase of 5.42.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.86. This value is below the healthy minimum of 20. It has increased from 5.74 (Mar 24) to 8.86, marking an increase of 3.12.
• For Earning Retention Ratio (%), as of Mar 25, the value is 87.54. This value exceeds the healthy maximum of 70. It has decreased from 92.96 (Mar 24) to 87.54, marking a decrease of 5.42.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.14. This value exceeds the healthy maximum of 70. It has decreased from 94.26 (Mar 24) to 91.14, marking a decrease of 3.12.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 23.85. This value is within the healthy range. It has decreased from 39.37 (Mar 24) to 23.85, marking a decrease of 15.52.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 13.83. This value is within the healthy range. It has decreased from 25.78 (Mar 24) to 13.83, marking a decrease of 11.95.
• For Enterprise Value (Cr.), as of Mar 25, the value is 16,601.08. It has increased from 12,215.32 (Mar 24) to 16,601.08, marking an increase of 4,385.76.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.33. This value exceeds the healthy maximum of 3. It has increased from 5.24 (Mar 24) to 6.33, marking an increase of 1.09.
• For EV / EBITDA (X), as of Mar 25, the value is 45.97. This value exceeds the healthy maximum of 15. It has increased from 29.18 (Mar 24) to 45.97, marking an increase of 16.79.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.32. This value exceeds the healthy maximum of 3. It has increased from 5.27 (Mar 24) to 6.32, marking an increase of 1.05.
• For Retention Ratios (%), as of Mar 25, the value is 87.53. This value exceeds the healthy maximum of 70. It has decreased from 92.95 (Mar 24) to 87.53, marking a decrease of 5.42.
• For Price / BV (X), as of Mar 25, the value is 11.98. This value exceeds the healthy maximum of 3. It has increased from 10.08 (Mar 24) to 11.98, marking an increase of 1.90.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.32. This value exceeds the healthy maximum of 3. It has increased from 5.27 (Mar 24) to 6.32, marking an increase of 1.05.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness